Alliance to Co-Market, Promote Lab Products

A leading provider of ultra-high throughput robotics for research and drug discovery, Protedyne Corp. (Windsor, CT, USA; www.protedyne.com), has expanded its alliance with Qiagen N.V. (Venlo, The Netherlands; www.qiagen.com), a leading supplier of technologies and products for the separation, purification, and handling of nucleic acids and proteins.

Under the new alliance, the two companies will jointly market and cross-promote the use of Protedyne's BioCube system in conjunction with Qiagen's QIAamp nucleic acid purification products as an integrated ultra-high-throughput sample preparation system for high-throughput research and molecular diagnostics markets. In addition, Qiagen will invest about U.S.$2 million in Protedyne's current financing.

The BioCube system of Protedyne addresses the needs of customers requiring ultra-high-throughput and fully integrated pre-analytic and analytic processing in molecular diagnostics and clinical research. Qiagen's nucleic acid sample preparation and handling technologies provide standardized procedures for all sample preparation steps in clinical research and molecular diagnostics, and complement Protedyne's industrial laboratory automation solutions for high-throughput sample processing in biotechnology, diagnostics, and for pharmaceutical companies.

"We are pleased to extend this important strategic move with Protedyne,” stated Noel Doheny, vice president, molecular diagnostics, Qiagen. "As partners based on the natural compatibility of our platforms in sample preparation and complete automation, Qiagen and Protedyne will further develop integrated customer solutions to meet the needs and the demands coming from this exciting emerging field.”





Related Links:
Protedyne
Qiagen